Anti-Human Alpha Defensin-5 (HD5) – Purified in vivo PLATINUM™ Functional Grade
Anti-Human Alpha Defensin-5 (HD5) – Purified in vivo PLATINUM™ Functional Grade
Product No.: D405
Clone 8C8 Target HD5 Formats AvailableView All Product Type Monoclonal Antibody Alternate Names DEFA5; DEF5; HD-5 Isotype Mouse IgG2b κ Applications ELISA , IHC FFPE , in vivo , WB |
Antibody DetailsProduct DetailsReactive Species Human Host Species Mouse Recommended Isotype Controls Recommended Dilution Buffer Immunogen Recombinant Human HD5 (aa 20-94). Endotoxin Level <0.5 EU/mg as determined by the LAL method Purity ≥98% monomer by analytical SEC ⋅ >95% by SDS Page Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. Product Preparation Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Pathogen Testing To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUM™ antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day 2-8°C RRIDAB_2829964 Applications and Recommended Usage? Quality Tested by Leinco WB ELISA Additional Applications Reported In Literature ? IHC FFPE Dot Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Clone 8C8 recognizes human alpha-defensin 5 (HD5). Background The colon lies adjacent to the small intestine and has heavy bacterial colonization from ingested food and water that is often contaminated with bacteria. Remarkably, the small intestine has a low microbial density. A special type of epithelial cell, called a Paneth cell, can be found clustered at the base of the tubular glands that lie between the villi of the inner surface of the small intestine. These cells secrete defensins which have been shown to have activity against both Gram-positive and Gram-negative microbes.3 Six human α-defensins, a subfamily of defensin peptides characterized by their cysteine spacing and disulfide connectivity2, have been identified. Human Paneth cells express α-defensin 5 (HD5) along with HD6. Paneth cells are most numerous in the ileum and have many features similar to those of myeloid cells. They are multifaceted cells with a large quantity of apically-located eosinophilic secretory granules containing lysozyme and other antimicrobial factors which are released upon bacterial stimulation.2 In addition, these cells express tumor necrosis factor alpha (TNF-a), CD1, and CD15.1 Paneth cells do not store defensins as fully processed or active peptides, rather they store them as inactive propeptides.2 They are released as mature peptides after trypsin digestion. Trypsin is also secreted from the Paneth cell granules. It has been reported that disrupted α-defensin processing in murine Paneth cells has initiated a vulnerability to enteric infection.2 HD5 expression levels have been found to be negatively correlated to intestinal infection. Additionally, studies have shown HD5 to be a strong antagonist towards human Papillomavirus infection. Furthermore, low expression of HD5 is thought to play a role in Crohn’s disease.3 Anti-Human Alpha Defensin-5 (HD5) Clone 8C8 has been shown to recognize the propeptide and the partially processed forms of HD5. However, clone 8C8 has been reported to scarcely recognize the mature peptide. There was no reported cross reactivity with HD6, lysozyme, or sPLA2. Antigen Distribution HD5 is highly expressed in the secretory granules of Paneth cells of the ileum. PubMed NCBI Gene Bank ID UniProt.org Leinco Antibody AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. Clone 8C8 is a monoclonal antibody generated from mouse and is specific for human alpha defensin-5 (HD5), a peptide highly expressed in Paneth cells of the small intestine. Its validated applications are immunohistochemistry and western blotting, typically on human tissue samplesstandard use cases involve detection of HD5 in colon or small intestinal tissues. There is no evidence in the provided search results that clone 8C8 is used in in vivo mouse studies. Available information indicates that its target is human HD5, and the antibody is derived from mouse, but there is no documentation of it being administered to live mice or used to modify mouse physiology or immune responses in vivo. The antibody is characterized by its suitability for in vitro techniques, specifically western blot and immunohistochemistry. If you are asking whether clone 8C8 has been injected into mice for depletion studies, for tracking cells, or for functional studies, the search results do not support such uses. Instead, it appears this antibody is primarily a research tool for detection of human HD5 in human tissues by immunohistochemical or biochemical analysis. If you meant a different clone (as other antibodies, like anti-CD8? clones such as 53-6.7, are frequently used in vivo in mice), please clarify. Based on current evidence, clone 8C8 is not conventionally used in in vivo mouse studies as per the available literature and product descriptions. Storage Temperature for Sterile Packaged Clone 8C8The search results do not directly specify the correct storage temperature for a sterile packaged clone 8C8 (which appears to be a monoclonal antibody). However, general best practices for storage of sterile reagentsespecially those used for research, diagnostics, or therapeuticscan be inferred from related scientific literature and regulatory guidelines. General Guidelines for Sterile Reagents
Recommendations Specific to 8C8Since clone 8C8 is a monoclonal antibody (as referenced in context of ab62757 at Abcam), the normal storage recommendation for such reagents is typically 2–8°C until needed. Always check the product datasheet or manufacturers instructions for the specific clone 8C8 in your possession, as variations in formulation or packaging can alter optimal storage conditions. If the datasheet is unavailable, store at 2–8°C as a conservative default. Summary Table
Key TakeawayFor sterile packaged clone 8C8 (antibody), the correct storage temperature is typically 2–8°C in a refrigerator, unless the manufacturer specifies otherwise. Always verify with the product datasheet or contact the supplier for the most accurate and specific storage instructions. If the product is lyophilized (dry), it may be stored at room temperature until reconstituted, after which refrigeration (2–8°C) is required. The most commonly referenced antibodies and proteins used alongside 8C8 in the literature are other anti-L1 monoclonal antibodies, specifically 39D4, M12B9, M2E9, and M7B6, which all target the vaccinia virus L1 protein. In experimental setups, these antibodies are frequently used for comparative studies of epitope specificity, binding affinity, and neutralization mechanisms. Additional relevant details:
For studies outside the vaccinia context (if your query refers to another field or protein), please specify, as the use of 8C8 may have alternative meanings in different research areas. However, in the context of vaccinia virus research, the above antibodies are the most relevant and commonly co-used proteins with 8C8. Based on the available search results, clone 8C8 appears to be referenced in scientific literature primarily as an antibody clone, specifically the Defensin alpha 5 Antibody (8C8). Primary Applications and UsesClone 8C8 has been documented for use in multiple research applications across various experimental techniques. The antibody demonstrates versatility in laboratory settings, with reported applications including: Immunological Techniques: The clone has been utilized in flow cytometry experiments, where it shows effectiveness at a concentration of 1 ?g per million cells when used for intracellular staining of MCF-7 cells. In immunohistochemistry applications, it demonstrates moderate nuclear and faint cytoplasmic staining in human skeletal muscle myocytes. Analytical Methods: Clone 8C8 has been employed in various analytical techniques including dot blot, ELISA, immunocytochemistry/immunofluorescence (at dilutions of 1:200-1:1000), and western blot (at 1:1000 dilution). Specialized Research ApplicationsIn cardiovascular medicine research, clone 8C8 has been mentioned alongside other antibody clones in studies involving C-reactive protein (CRP) analysis, where it appears to be used in conjunction with other clones for specific protein detection assays. Methodological ConsiderationsThe literature indicates that when using clone 8C8, researchers should be aware that the observed molecular weight of target proteins may vary from predicted values due to post-translational modifications, cleavages, relative charges, and other experimental factors. This suggests that clone 8C8 requires careful optimization and validation in experimental protocols. The available evidence suggests that clone 8C8 serves as a reliable research tool across multiple experimental platforms, though the specific findings and outcomes of studies utilizing this clone would require access to the full research papers for more detailed analysis. References & Citations1. Porter, EM. et al. (1997) Infect Immun. 65(6):2389-95. 2. Ghosh, D. et al. (2002) Nat Immunol. 3(6):583-90. 3. Wehkamp, J. et al. (2019) Proc Natl Acad Sci U S A. 116(9): 3746–3751. 4. Schwaderer, AL. et al. (2012) PLoS One. 7(2):e31712. 5. Hains, D. et al. (2016) US Patent Application Publication No. US 2016/0069905 A1 6. Shen, B. et al. (2005) J Clin Pathol. 58(7):687-94. 7. Ranki, A. et al. (2015) Clin Immunol. 158(2):212-20. 8. Hulscher, JB. et al. (2016) Pediatr Res. 80(2):306-10. Technical ProtocolsCertificate of Analysis |
Formats Available
